FinTechFunding

PharmAust: Continues testing COVID-19 treatment

  • PharmAust (PAA) has revealed preliminary results show its drugs are effective in inhibiting COVID-19 in human lung cells
  • Researchers in Melbourne have been testing the effect monepantel (MPL) and monepantel sulfone (MPLS) has on the deadly virus
  • This recent testing found MPL and MPLS inhibited COVID-19 in human lung cells by up to 95 per cent
  • PharmAust said following these initial results, further testing will now undertaken to better understand the drug’s effect
  • PharmAust’s Chief Scientific Officer, Richard Mollard, also said the was very pleased with these latest results
  • Shares in PAA are trading 4.26 per cent in the green at 24.5 cents each
Previous article
Perpetual Resources: Receives positive wet screening test results
Next article
Metalicity: Confirms further high-grade gold at Liepold
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Visa Strengthens Ties as Anchor Investor in PayPay IPO

Visa commits to supporting PayPay's growth through IPO investment.Highlights: Visa invests as anchor in PayPay's IPO.This move highlights...
FinTech

Santander and Mastercard Complete Europe’s First Live Agentic AI Transaction

This groundbreaking transaction marks a milestone in AI-driven financial technology.Highlights: Santander and Mastercard execute Europe’s first agentic AI...
FinTech

Apple Strengthens Reach with Apple Pay Launch in India

Apple Pay expands its footprint, aiming to capture the Indian digital payments market.Highlights: Apple Pay officially launches in...
FinTech

Brink’s Strengthens Position with $6.6B NCR Acquisition

Brink's expands its services through strategic acquisition of NCR's Atleos.Highlights: Brink's acquires NCR Atleos for $6.6 billion.The deal...

Follow us

Daily fintech insights, global payment trends, and industry moves that matter. Because in finance, timing is everything.

Company

Other Sites

MedNextz.com

Latest News

Visa Strengthens Ties as Anchor Investor in PayPay IPO

FinTech 0
Visa commits to supporting PayPay's growth through IPO investment.Highlights:...

Santander and Mastercard Complete Europe’s First Live Agentic AI Transaction

FinTech 0
This groundbreaking transaction marks a milestone in AI-driven financial...

Apple Strengthens Reach with Apple Pay Launch in India

FinTech 0
Apple Pay expands its footprint, aiming to capture the...

Popular News

Visa Strengthens Ties as Anchor Investor in PayPay IPO

FinTech 0
Visa commits to supporting PayPay's growth through IPO investment.Highlights:...

Santander and Mastercard Complete Europe’s First Live Agentic AI Transaction

FinTech 0
This groundbreaking transaction marks a milestone in AI-driven financial...

Apple Strengthens Reach with Apple Pay Launch in India

FinTech 0
Apple Pay expands its footprint, aiming to capture the...

© 2026 FintechInshorts. All Rights Reserved.